在各地持续释放吸引外资的强烈信号之际，位于长三角区域的江苏太仓，正以"德企之乡"IP演绎着稳外资的鲜活样本。2024年，太仓完成实际使用外资4.74亿美 元，博泽汽车等16家外企利润再投资2.02亿美元，占太仓实际使用外资的42.6%，同比增长112.8%。 2023年年初，证券时报记者曾实地探访太仓，探究其成为"德企之乡"的内在动因与发展趋势。时隔两年，记者近日再次走进太仓，调研这座江南小城的德企投资动 态，剖析其为稳外资提供的县域发展样本。 集聚效应催生投资加速度 "太仓最近两年每年新引进的德企约30家。"中德（太仓）中小企业合作示范区管理办公室主任段月强接受证券时报记者采访时透露。目前，太仓集聚的德企超过550 家，总投资超60亿美元，年工业产值超670亿元，"隐形冠军"企业有60多家。 伯曼太仓公司2024年年初注册成立，这是在太仓落户的第500家德企。仅一年多的时间，伯曼太仓项目已从效果图变成了实体工厂建筑。伯曼亚洲&中国首席财务 官、太仓项目负责人黄晓桦接受证券时报记者采访时表示，太仓生产基地目前正处于全面开工建设阶段，预计6月份将竣工验收。 投资1亿欧元新建的伯曼太仓输送分拣设备及输送带项目，占 ...

Core Viewpoint - Xinlei Co., Ltd. reported a significant increase in net profit for Q1 2025 despite a decline in revenue, indicating strong operational efficiency and successful management of relocation impacts [1] Financial Performance - The company's Q1 2025 revenue was 128 million yuan, representing a year-on-year decrease of 22.78% [1] - Net profit reached 394 million yuan, showing a remarkable year-on-year growth of 3015.05% [1] - Basic earnings per share were reported at 2.5 yuan [1]

Core Viewpoint - The meeting between China's Vice Minister of Commerce and the Czech Deputy Minister of Industry and Trade emphasizes the commitment to enhance bilateral trade relations and cooperation in various sectors, including green, digital, and smart manufacturing [1] Group 1: Bilateral Trade Relations - China expresses willingness to expand imports of advantageous Czech products [1] - The Czech Republic values the development of economic and trade relations with China, particularly in traditional sectors like machinery manufacturing and machine tool processing [1] Group 2: Cooperation and Multilateral Trade - Both parties aim to strengthen dialogue and expand cooperation lists to jointly uphold a rules-based multilateral trading system, opposing protectionism and unilateralism [1] - The Czech Republic supports free trade and advocates for the maintenance of the multilateral trading system, indicating a desire for stable development of China-Europe economic relations [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 回购股份期限：自董事会审议通过回购方案之日起12个月内。 ● 相关股东是否存在减持计划：截至公告披露日，公司董事、监事、高级管理人员、控股股东、实际控 制人及一致行动人、持股5%以上股东在未来三个月、未来六个月内暂无减持计划。若未来前述主体提 出减持计划，公司将根据相关法律法规规定及时履行信息披露义务。 ● 相关风险提示： 1、本次回购事项存在回购期限内股票价格持续超出回购价格上限，进而导致本次回购方案无法顺利实 施或者只能部分实施等不确定性风险； 2、本次回购存在因对公司股票交易价格产生重大影响的重大事项发生或公司董事会决定终止本次回购 方案等而无法实施的风险； 3、本次回购股份拟用于员工持股计划或股权激励，可能存在因员工持股计划或股权激励方案未能经公 司股东大会审议通过、股权激励认购对象放弃认购等原因，导致已回购股份无法全部转让的风险。本次 回购的股份若未能在股份回购实施完成之后法定期限内用于员工持股计 ...

Core Viewpoint - The Shenzhen Stock Exchange held its first collective performance briefing for listed companies in 2024, focusing on the theme "New Growth for Enterprises: Private Enterprises Competing in the Middle Stream," showcasing the latest developments of private enterprises and addressing investor concerns regarding technological innovation, tariff challenges, internationalization, and development strategies [1]. Group 1: Technological Innovation - Innovation is identified as the core driving force for the development of the private economy, with Shenzhen's private listed companies making significant investments in R&D, technology innovation, and patent accumulation [3]. - Jianfan Bio focuses on the R&D, production, and sales of biomedical materials and high-tech medical devices, particularly excelling in blood purification technology, and plans to enhance production management and diversify its product line [3]. - ZhiJian Electronics, a leader in consumer lithium-ion batteries, is committed to a forward-looking R&D strategy and aims to enhance its core competitive advantages while exploring market growth opportunities [3]. - Wanfu Bio sees digital pathology as a significant transformation opportunity and is developing comprehensive digital pathology solutions to reduce doctors' workloads [4]. - Xinlitai is exploring AI applications in drug discovery and clinical research to improve innovation efficiency and plans to deepen AI's role in drug design and data mining [4]. Group 2: Tariff Challenges - Companies are closely monitoring international trade policies and are implementing measures such as increasing domestic sales and developing new overseas markets to mitigate the impact of high tariffs imposed by the U.S. [6]. - Zongshen Power reported that its domestic sales accounted for 51.99% of total revenue in 2024, slightly higher than export business, and has taken proactive measures to address tariff risks [6]. - Yunjigroup highlighted that its supply chain has a high localization rate, effectively mitigating tariff fluctuations, and is capitalizing on new overseas projects due to the ongoing high prosperity cycle in the mining industry [7]. - Jianfan Bio is expanding into new markets while increasing its overseas business share, particularly in heavy liver disease and critical illness applications [7]. - Wanfu Bio has over 20 years of experience in international markets and continues to innovate to maintain growth in its international business despite tariff challenges [7]. Group 3: Development Trends - Shenzhen's private listed companies demonstrate resilience and vitality, with a significant number of companies contributing to economic development and technological innovation [9]. - As of March 2025, there are 2,181 private listed companies in Shenzhen, accounting for 76% of the total, with a combined market value of 22.65 trillion yuan, representing 69% of the total market value [9]. - In 2023, 582 private enterprises disclosed their annual reports, achieving a total revenue of 6.25 trillion yuan, a year-on-year increase of 6.62%, and a net profit of 419.9 billion yuan, a growth of approximately 1% [9]. - Jianfan Bio is investing in high-value resin and medical device projects, aiming to enhance market share and secure product supply [10]. - Xinlitai is transitioning from generic to innovative drugs, with increasing revenue contributions from new patented products [11].

Group 1 - Trump's recent shift in tone suggests a willingness to negotiate with China regarding tariffs, indicating a potential easing of tensions [8][9][12] - The volatility in Trump's stance has led to significant market reactions, with over $4 trillion evaporating from the stock market, representing 14% of the U.S. GDP [4][6] - The new tariff policies have adversely affected American citizens, with over 30% of their funds tied to the stock market, leading to concerns over pension funds [6][8] Group 2 - Trump's negotiations with Japan are seen as a strategy to pressure other countries into accepting stringent U.S. conditions, although Japan is cautious and not in a hurry to finalize agreements [19][21] - The Federal Reserve, led by Powell, has faced criticism from Trump for not aligning with his economic policies, particularly regarding interest rates and inflation concerns stemming from the tariff policies [23][25] - The ongoing trade tensions have prompted countries like Mexico and Canada to adopt ambiguous stances, while China is strengthening trade ties with other regions, potentially undermining U.S. leverage [33][35]

从指数持仓来看，中证中国内地企业全球工业综合指数十大权重分别为：宁德时代（6.03%）、京沪高 铁（1.82%）、汇川技术（1.37%）、中国建筑（1.16%）、三一重工（1.15%）、顺丰控股（1.03%）、 国电南瑞（0.96%）、中远海控（0.93%）、隆基绿能（0.92%）、中国中车（0.87%）。 金融界4月18日消息，A股三大指数收盘涨跌不一，中证中国内地企业全球工业综合指数 (CN工业综 合，H30377)报2273.92点。 数据统计显示，中证中国内地企业全球工业综合指数近一个月下跌10.58%，近三个月下跌2.51%，年至 今下跌4.95%。 据了解，中证中国内地企业全球行业综合指数系列从中证中国内地企业全球综合指数样本中按中证行业 分类标准进行分类，再以各自行业全部证券作为相应行业指数的指数样本，形成中证中国内地企业全球 行业综合指数系列，以反映中国内地企业中不同行业证券的整体表现。该指数以2004年12月31日为基 日，以1000.0点为基点。 从中证中国内地企业全球工业综合指数持仓的市场板块来看，深圳证券交易所占比46.82%、上海证券 交易所占比45.68%、香港证券交易所占比4.3 ...

Core Viewpoint - The stability of cash flow, rather than the scale of assets, is crucial for quality of life and investment success, especially in uncertain market conditions [1] Group 1: Cash Flow Index ETFs - A new batch of cash flow index ETFs has emerged, focusing on companies that generate real cash flow, serving as a strategy to navigate market volatility [1] - The China Securities Cash Flow Total Return Index has achieved a remarkable annual return of 40% in a turbulent market [2] Group 2: Investment Strategies - The free cash flow strategy is based on three winning logic points: 1. It focuses on real profitability by looking beyond financial statements, as free cash flow is based on actual cash inflows and outflows [4] 2. It combines high dividend yields with growth potential, providing a dual revenue engine [5] 3. It employs a dynamic rebalancing mechanism to capture undervalued stocks, allowing for timely adjustments to the index [9] Group 3: Performance Metrics - The index demonstrated resilience during bear markets, with a mere 2.76% decline in 2022 when the CSI 300 fell by 21.6% [6] - In bull markets, it outperformed with a 40.94% increase in 2024, achieving an excess return of 27 percentage points [6] - Since its inception in 2013, the index has accumulated a total return of 587.53% [6] Group 4: Index Composition - The index employs a "barbell strategy," including both cash-rich cyclical leaders like coal and petrochemicals, and high ROE growth sectors such as home appliances and automobiles [7] - The top ten constituent stocks, including China Shenhua and Midea Group, account for over 60% of the index, providing stable dividends while retaining growth potential [7] Group 5: Future Outlook - The market is expected to reassess value anchors, with state-owned enterprises facing value re-evaluation as cash flow assets become essential for risk-averse investments [9] - The upcoming issuance of the China Securities Cash Flow ETF may capture more certainty in the era of cash being king [9]

机构指出，多方增量资金明确，稳市资金更加积极，下方空间有限。 【财经日历】 2025全球机器学习技术大会。 | 3 | 盘前必读 | | 外盘怎么样 // | | | --- | --- | --- | --- | --- | | 名称 | | 现价 | 涨跌 | 涨跌幅 | | 道琼斯工业指数 | | 39142.23 | -527.16 | -1.33% | | 纳斯达克指数 | | 16286.45 c | -20.71 | -0.13% | 美股周四涨跌不一，投资者在假期前保持谨慎，同时关注贸易谈判进展与利率前景。 截至当天收盘，道琼斯工业平均指数下跌527.16点，报39142.23点，跌幅1.33%；标准普尔500指数上涨7.00点，报5282.70点，涨幅0.13%；纳斯达克综合指 数下跌20.71点，报16286.45点，跌幅0.13%。本周三大指数均录得周线下跌，标普500指数累计下跌1.5%，纳指下跌2.6%，道指跌幅达2.7%。 大型科技股走势分化。谷歌母公司Alphabet下跌1.4%，此前联邦法官裁定谷歌在在线广告技术市场存在非法垄断行为。微软下跌逾1%；亚马逊、Meta与特 斯拉微 ...

Core Viewpoint - The company, Southern Precision, announced that there have been no significant changes in its recent operational situation and external business environment despite a notable stock price fluctuation [1] Group 1: Stock Performance - Southern Precision's A-share stock price experienced a cumulative deviation of 20.00% over three consecutive trading days from April 15 to April 17, 2025, indicating abnormal trading activity [1] Group 2: Operational Status - The company confirmed that its recent operational situation has not undergone any major changes, and there are no undisclosed significant matters related to the company, its controlling shareholders, or actual controllers [1] Group 3: Regulatory Compliance - The company has received acceptance from the Shenzhen Stock Exchange regarding its refinancing application, adhering to regulatory requirements [1]